Ascendis Pharma share price logo

Ascendis Pharma

NASDAQ: ASND

Large Cap

$227.83

-0.24

(-0.11%)

as on

Ascendis Pharma Stock Performance

as on October 1, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $226.18
    $230.97
    downward going graph

    0.72%

    Downside

    1.38%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $186.05
    $282.15
    downward going graph

    18.34%

    Downside

    23.84%

    Upside

    downward going graph

Ascendis Pharma share price movements today

Previous Close
$228.07
Open
$227.03
Volume
827.7K
Market Cap
$15.0B
Day's Low - High
$226.18 - $230.97
52 Week Low - High
$186.05 - $282.15

Ascendis Pharma Historical Returns

1 Month Return
-12.46 %
3 Month Return
-14.92 %
1 Year Return
+ 11.62 %
3 Year Return
+ 143.3 %
5 Year Return
+ 40.42 %

Ascendis Pharma Stock Fundamentals & Key Indicators

Check Ascendis Pharma market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$15.0B

EPS (TTM)

12.1

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

16.32

Industry PE ratio

8.46

PEG Ratio

0.03

EBITDA

78.1M

Revenue (TTM)

1.1B

Profit Margin

90.19%

Return On Equity TTM

190.44%

Ascendis Pharma vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Ascendis Pharma with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
StrongBuy$15.0B40.42%16.3290.19%0.00%
StrongBuy$43.8B604.88%-22.690.00%0.00%
Neutral$81.2B-43.54%-24.76-12.57%0.00%
StrongBuy$133.4B189.75%30.3886.04%0.00%
Buy$77.3B32.85%17.7984.86%0.49%

Stock Returns calculator for Ascendis Pharma Stock including INR - Dollar returns

The Ascendis Pharma stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Ascendis Pharma investment value today

Current value as on today

₹1,20,402

Returns

₹20,402

(+20.4%)

Returns from Ascendis Pharma Stock

₹11,621 (+11.62%)

Dollar Impact

₹8,781 (+8.78%)

Analyst Recommendation on Ascendis Pharma Stock

Based on 14 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 14 analysts, 100% of analysts recommend a 'BUY' rating for Ascendis Pharma. Average target price of $309.48

Ascendis Pharma Share Price Target

Get share price movements and forecasts by analysts on Ascendis Pharma.

What analysts predicted

26.38%UPSIDE

Target Price

$309.48

Current Price

$227.83

Analyzed by

14 Analysts

High

$360

Target

$309.48

Low

$273

Ascendis Pharma target price $309.48, a slight upside of 26.38% compared to current price of $227.83. According to 14 analysts rating.

Indian Investors' Interest in Ascendis Pharma Stock

Search interest for Ascendis Pharma Stock has increased by 37% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:37% versus previous 30 day period

Ascendis Pharma Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
95
35
57
173
100
158
213
245
250
344
Gross Profit
88
24
46
159
83
126
191
217
229
312
Operating Income
-49
-133
-96
0
-104
-52
10
9
25
63
EBITDA
-46
-87
-71
-37
-44
2
-53
39
23
68
Interest Expense
77
19
25
-56
44
33
19
61
68
14
Depreciation
4
2
1
4
4
4
4
4
4
4
Income Before Tax
-128
-109
-98
-37
-93
-35
-57
-26
-48
233
Income Tax Expense
2
0
1
1
1
3
3
6
-688
23
Net Income
-131
-109
-99
-38
-94
-38
-60
-33
639
210
Net Profit Margin
92.11%
68.15%
80.63%
91.94%
82.65%
80.10%
89.54%
88.91%
91.37%
90.64%

Ascendis Pharma Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
1
10
13
6
7
51
266
363
691
Gross Profit
1
10
13
6
4
39
222
319
588
Operating Income
-111
-154
-226
-330
-451
-561
-455
-278
-130
EBITDA
-109
-150
-210
-407
-364
-529
-411
-290
-109
Interest Expense
0
0
1
1
3
30
44
65
77
Depreciation
0
0
6
9
15
17
18
17
16
Income Before Tax
-124
-130
-218
-419
-383
-577
-474
-373
-204
Income Tax Expense
0
0
0
0
0
5
7
4
14
Net Income
-123
-130
-218
-418
-383
-583
-481
-378
-219
Net Profit Margin
100.00%
100.00%
100.00%
100.00%
54.71%
76.28%
83.36%
87.83%
85.08%

Ascendis Pharma Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-131
-109
-99
-38
-94
-38
-60
-33
639
210
Operating Cash Flow
-101
-61
-56
-87
-14
-7
2
70
-7
286
Investing Cash Flow
7
0
0
0
0
-4
0
-3
-6
-2
Financing Cash Flow
18
-2
427
0
-18
6
38
8
-37
-46
Change in Cash
-71
-61
366
-65
-41
-23
45
76
-55
234

Ascendis Pharma Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-123
-130
-218
-418
-383
-583
-481
-378
-219
Operating Cash Flow
-95
-138
-175
-271
-417
-495
-467
-306
51
Investing Cash Flow
0
-2
-5
-291
-110
61
286
6
-8
Financing Cash Flow
124
203
493
602
351
396
134
443
34
Change in Cash
15
82
320
-13
-138
-1
-52
167
122

Global Institutional Holdings in Ascendis Pharma

Check out the Institutions with significant holdings in Ascendis Pharma.

Funds
Holdings
Peter Kolchinsky
16.48%
iShares
2.24%
MFS Series Trust IV
2.05%
Joseph Edelman
1.87%
VANGUARD SPECIALIZED FUNDS
1.68%

Ascendis Pharma News & Key Events

  • img

    Today's Timeline - 15 September

    Tue, 11:26 PM

    -

    Ascendis Pharma regains rights to TransCon technology and announces a $400 million share buyback program.

Insights on Ascendis Pharma

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, ASND has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 6 quarters, 100.95M → 344.90M (in $), with an average increase of 20.9% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 years, ASND stock has moved up by 143.3%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 597.7% return, outperforming this stock by 586.1%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 639.68M → 210.39M (in $), with an average decrease of 67.1% per quarter

About Ascendis Pharma

Ascendis Pharma A/S is a biopharmaceutical enterprise dedicated to advancing therapeutic solutions for critical medical conditions that currently lack effective treatments. Its commercialized offering is SKYTROFA, a therapy prescribed for individuals suffering from growth hormone deficiency (GHD). The company boasts a robust development pipeline, featuring several TransCon-branded candidates. These include TransCon Growth Hormone (hGH), which is being progressed for pediatric GHD patients in Japan and for adults with GHD. Also under development are TransCon parathyroid hormone for adults with hypoparathyroidism, and TransCon CNP, aimed at treating pediatric achondroplasia. Further expanding its innovative portfolio, Ascendis is also developing a TransCon toll-like receptor (TLR) 7/8 agonist for intratumoral administration, alongside TransCon IL-2 ß/g, designed for systemic delivery. Founded in 2006, this enterprise maintains its corporate headquarters in Hellerup, Denmark.
OrganisationAscendis Pharma
HeadquartersTuborg Boulevard 12, Hellerup, CR, 2900, DK
IndustryBiotechnology
CEOJan Moller Mikkelsen

Key Management of Ascendis Pharma

Name

Title

Mr. Scott T. Smith

CFO, Executive VP & Member of Executive Board

Mr. Michael Wolff Jensen L.L.M.

Executive VP, Chief Legal Officer & Member of the Executive Board

Mr. Mads Bodenhoff

Senior VP, Head of Finance & Principal Accounting Officer

Mr. Chad Fugure

Vice President of Investor Relations

Mr. Flemming Steen Jensen

Executive Vice President of Product Supply & Quality

Ms. Sherrie Lynn Glass

Chief Business Officer

Mr. Jan Moller Mikkelsen

President, CEO, Member of Executive Board & Executive Director

Dr. Kennett Sprogoe Ph.D.

Executive VP and Head of Research & Product Development

Mr. Joseph Kelly

Head of U.S. Commercial of Endocrinology

Ms. Pedersen Anni Lotte Kirstine Sonderbjerg

Executive VP, Chief Administrative Officer & Member of the Executive Board

FAQs

What is Ascendis Pharma share price today?

Ascendis Pharma share price today is $227.83 as on at the close of the market. Ascendis Pharma share today touched a day high of $230.97 and a low of $226.18.

What is the 52 week high and 52 week low for Ascendis Pharma share?

Ascendis Pharma share touched a 52 week high of $282.15 on and a 52 week low of $186.05 on . Ascendis Pharma stock price today i.e. is closed at $227.83,which is 19.25% down from its 52 week high and 22.45% up from its 52 week low.

What is Ascendis Pharma's market capitalisation today?

Ascendis Pharma market capitalisation is $0.02T as on .

How to invest in Ascendis Pharma Stock (ASND) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Ascendis Pharma on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Ascendis Pharma Stock (ASND) from India?

Indian investors can start investing in Ascendis Pharma (ASND) shares with as little as ₹95.83000183105469 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹958.30 in Ascendis Pharma stock (as per the Rupee-Dollar exchange rate as on ). Based on Ascendis Pharma share’s latest price of $227.83 as on October 1, 2026 at 8:45 am IST, you will get 0.0439 shares of Ascendis Pharma. Learn more about fractional shares .

What are the returns that Ascendis Pharma has given to Indian investors in the last 5 years?

Ascendis Pharma stock has given 40.42% share price returns and 29.42% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?